RobertoCaricchioMD
Rheumatology • Worcester, MALupus & Related
Professor of Medicine, Chief, Division of Rheumatology
Dr. Caricchio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
119 Belmont Street
Worcester, MA 01605Phone+1 508-334-5224Fax+1 508-334-5654
Education & Training
Temple University HospitalResidency, Internal Medicine, 2008 - 2014- Temple University HospitalFellowship, Rheumatology, 2012 - 2013
University of Cattolica del Sacro CuoreClass of 1993
Certifications & Licensure
MA State Medical License 2022 - 2025
PA State Medical License 2005 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- JBT-101 in Systemic Lupus Erythematosus (SLE) Start of enrollment: 2017 Dec 21
- Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection. Start of enrollment: 2020 Apr 02
Publications & Presentations
PubMed
- 49 citationsInterleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications.Nicola Potere, Marco Giuseppe Del Buono, Roberto Caricchio, Paul C Cremer, Alessandra Vecchié
Ebiomedicine. 2022-11-01 - 87 citationsCalming the cytokine storm in COVID-19.Randy Q. Cron, Roberto Caricchio, W. Winn Chatham
Nature Medicine. 2021-09-03 - 459 citationsOn the Alert for Cytokine Storm: Immunopathology in COVID-19.Lauren A. Henderson, Scott W. Canna, Grant S. Schulert, Stefano Volpi, Pui Y. Lee
Arthritis & Rheumatology. 2020-07-01
Press Mentions
Lupus Center at UMass Chan Investigates CAR T-cell Therapy for Severe or Unresponsive Lupus NephritisJuly 15th, 2024- Anakinra Improved Survival in Hospitalized COVID-19 PatientsSeptember 7th, 2021
- Canakinumab Fails to Improve Survival in Covid-19 TrialJuly 21st, 2021
- Join now to see all
Grant Support
- SLE Autoantigen Trafficking And Display During ApoptosisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2008
- SLE Autoantigen Trafficking And Display During ApoptosisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004–2008
- Apoptotic Nucleosomal DNA And Its Relevance In SLENational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004–2006
Professional Memberships
- Fellow
Other Languages
- Italian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
